Therapeutic effects of exendin-4 on spinal cord injury via restoring autophagy function and decreasing necroptosis in neuron.
CNS Neurosci Ther · 2024
Last updated 2026-05-28In a study on rats with spinal cord injuries, the drug exendin-4 (EX-4) improved motor function and strength within 4 weeks. EX-4 also helped restore autophagy (a cell cleanup process) and reduced cell death linked to injury by targeting specific proteins.
AI summary of the abstract below.
| Journal | CNS Neurosci Ther, 2024 |
|---|---|
| Citations | 4 |
| Relative citation ratio | 0.74 |
| NIH percentile | 40 |
| Molecules | — |
Abstract
AIMS: Necroptosis is one of programmed death that may aggravate spinal cord injury (SCI). We aimed to investigate the effect and mechanism of exendin-4 (EX-4) on the recovery of motor function and necroptosis after SCI.
METHODS: The SD rats with left hemisection in the T10 spinal cord as SCI model were used. The behavior tests were measured within 4 weeks. The effects of EX-4 on necroptosis-associated proteins and autophagy flux were explored. In addition, the SHSY5Y cell model was introduced to explore the direct effect of EX-4 on neurons. The effect of lysosome was explored using mTOR activator and AO staining.
RESULTS: EX-4 could improve motor function and limb strength, promote the recovery of autophagy flux, and accelerate the degradation of necroptosis-related protein at 3 d after injury in rats. EX-4 reduced lysosome membrane permeability, promoted the recovery of lysosome function and autophagy flux, and accelerated the degradation of necroptosis-related proteins by inhibiting the phosphorylation level of mTOR in the SHSY5Y cell model.
CONCLUSION: Our results demonstrated that EX-4 may improve motor function after SCI via inhibiting mTOR phosphorylation level and accelerating the degradation of necroptosis-related proteins in neurons. Our findings may provide new therapeutic targets for clinical treatment after SCI.
Verbatim abstract via PubMed 39004783 ↗